These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3193137)

  • 1. Prognostic factors for life expectancy in multiple sclerosis analysed by Cox-models.
    Riise T; Grønning M; Aarli JA; Nyland H; Larsen JP; Edland A
    J Clin Epidemiol; 1988; 41(10):1031-6. PubMed ID: 3193137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival in multiple sclerosis.
    Poser S; Kurtzke JF; Poser W; Schlaf G
    J Clin Epidemiol; 1989; 42(2):159-68. PubMed ID: 2918325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival and cause of death in multiple sclerosis: a 60-year longitudinal population study.
    Lunde HMB; Assmus J; Myhr KM; Bø L; Grytten N
    J Neurol Neurosurg Psychiatry; 2017 Aug; 88(8):621-625. PubMed ID: 28365589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors for survival in multiple sclerosis: a longitudinal, population based study in Møre and Romsdal, Norway.
    Midgard R; Albrektsen G; Riise T; Kvåle G; Nyland H
    J Neurol Neurosurg Psychiatry; 1995 Apr; 58(4):417-21. PubMed ID: 7738546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excess Mortality in Patients with Multiple Sclerosis Starts at 20 Years from Clinical Onset: Data from a Large-Scale French Observational Study.
    Leray E; Vukusic S; Debouverie M; Clanet M; Brochet B; de Sèze J; Zéphir H; Defer G; Lebrun-Frenay C; Moreau T; Clavelou P; Pelletier J; Berger E; Cabre P; Camdessanché JP; Kalson-Ray S; Confavreux C; Edan G
    PLoS One; 2015; 10(7):e0132033. PubMed ID: 26148099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival pattern and cause of death in patients with multiple sclerosis: results from an epidemiological survey in north east Scotland.
    Phadke JG
    J Neurol Neurosurg Psychiatry; 1987 May; 50(5):523-31. PubMed ID: 3495637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis.
    Cottrell DA; Kremenchutzky M; Rice GP; Koopman WJ; Hader W; Baskerville J; Ebers GC
    Brain; 1999 Apr; 122 ( Pt 4)():625-39. PubMed ID: 10219776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognosis and life expectancy in multiple sclerosis].
    Angstwurm H
    Versicherungsmedizin; 1991 Apr; 43(2):52-4. PubMed ID: 2058080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors for survival in multiple sclerosis.
    Lević ZM; Dujmović I; Pekmezović T; Jarebinski M; Marinković J; Stojsavljević N; Drulović J
    Mult Scler; 1999 Jun; 5(3):171-8. PubMed ID: 10408717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age at disability milestones in multiple sclerosis.
    Confavreux C; Vukusic S
    Brain; 2006 Mar; 129(Pt 3):595-605. PubMed ID: 16415309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival and predictors of disability in Turkish MS patients. Turkish Multiple Sclerosis Study Group (TUMSSG).
    Kantarci O; Siva A; Eraksoy M; Karabudak R; Sütlaş N; Ağaoğlu J; Turan F; Ozmenoğlu M; Toğrul E; Demirkiran M
    Neurology; 1998 Sep; 51(3):765-72. PubMed ID: 9748024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disability and survival of multiple sclerosis in Saskatoon, Saskatchewan.
    Hader WJ
    Can J Neurol Sci; 2010 Jan; 37(1):28-35. PubMed ID: 20169770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada.
    Kingwell E; van der Kop M; Zhao Y; Shirani A; Zhu F; Oger J; Tremlett H
    J Neurol Neurosurg Psychiatry; 2012 Jan; 83(1):61-6. PubMed ID: 21865212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic indicators in multiple sclerosis.
    Poser S; Poser W; Schlaf G; Firnhaber W; Lauer K; Wolter M; Evers P
    Acta Neurol Scand; 1986 Nov; 74(5):387-92. PubMed ID: 3825497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A representative cohort of patients with non-progressive multiple sclerosis at the age of normal life expectancy.
    Skoog B; Runmarker B; Winblad S; Ekholm S; Andersen O
    Brain; 2012 Mar; 135(Pt 3):900-11. PubMed ID: 22366800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Life expectancy in patients attending multiple sclerosis clinics.
    Sadovnick AD; Ebers GC; Wilson RW; Paty DW
    Neurology; 1992 May; 42(5):991-4. PubMed ID: 1579256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the natural history and prognostic features of early onset and adult onset multiple sclerosis in Jordanian population.
    El-Salem K; Khader Y
    Clin Neurol Neurosurg; 2007 Jan; 109(1):32-7. PubMed ID: 16870328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multiple sclerosis mortality in Poland].
    Cendrowski W
    Neurol Neurochir Pol; 1986; 20(5):444-7. PubMed ID: 3587514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension.
    Myhr KM; Riise T; Vedeler C; Nortvedt MW; Grønning R; Midgard R; Nyland HI
    Mult Scler; 2001 Feb; 7(1):59-65. PubMed ID: 11321195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The natural history of multiple sclerosis.
    Weinshenker BG; Ebers GC
    Can J Neurol Sci; 1987 Aug; 14(3):255-61. PubMed ID: 3311324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.